Johnson & Johnson Reports Q3 2021 Results
New Brunswick, N.J. (October 19, 2021) – Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2021. “Our third-quarter results demonstrate solid performance across Johnson & Johnson, driven by robust above-market results in Pharmaceuticals, ongoing recovery in Medical Devices, and strong growth in Consumer Health,” said Alex Gorsky, Chairman and Chief Executive Officer. “In the face of evolving marketplace dynamics resulting from the effects of COVID-19 and other global trends, we have continued to demonstrate the responsiveness and agility required to meet the needs of ou...
Source: Johnson and Johnson - October 19, 2021 Category: Pharmaceuticals Tags: Financial Source Type: news

Ultrasound finds swollen glands on patients after COVID-19 vaccine
Unilateral axillary adenopathy after receiving the Pfizer-BioNTech COVID-1...Read more on AuntMinnie.comRelated Reading: Swollen glands from COVID vaccine more prevalent in breast imaging FDG-PET lymph node uptake after COVID-19 vaccines mimics cancer Adenopathy may occur after COVID-19 vaccination COVID-19 vaccine affects imaging results, researchers warn Ultrasound shows lymph node changes after COVID-19 vaccine (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 19, 2021 Category: Radiology Source Type: news

What Scientists Know About the Risk of Breakthrough Covid Deaths
Deaths among people who have been fully vaccinated remain rare, but older adults and those with compromised immune systems are at much higher risk. (Source: NYT Health)
Source: NYT Health - October 19, 2021 Category: Consumer Health News Authors: Emily Anthes Tags: your-feed-science Disease Rates Coronavirus (2019-nCoV) Vaccination and Immunization Cancer Multiple Myeloma Immune System Antibodies Multiple Myeloma Research Foundation Powell, Colin L your-feed-health Source Type: news

How a medieval 'leechbook' could be the latest cutting-edge treatment to beat superbugs
The WHO lists antimicrobial resistance as a top ten global health threat, saying that by 2050 it will kill more people than cancer. Could novel vaccines provide new ways to defeat superbugs? (Source: the Mail online | Health)
Source: the Mail online | Health - October 19, 2021 Category: Consumer Health News Source Type: news

Cancer Patients With Poor Antibody Response to COVID-19 Vaccines Also...
Patients with the blood cancer multiple myeloma often mount a poor antibody response to COVID-19 vaccines. Mount Sinai researchers have now discovered that these patients also have a weak response...(PRWeb October 19, 2021)Read the full story at https://www.prweb.com/releases/cancer_patients_with_poor_antibody_response_to_covid_19_vaccines_also_lack_secondary_immune_response_study_shows/prweb18272203.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 19, 2021 Category: Pharmaceuticals Source Type: news

Doctors explain why fully vaccinated Colin Powell was at increased risk of death from COVID-19
Doctors say Colin Powell's age, his battle with multiple myeloma - a type of blood cancer - and Parkinson's contributed to his heightened risk of death from Covid despite being fully vaccinated. (Source: the Mail online | Health)
Source: the Mail online | Health - October 18, 2021 Category: Consumer Health News Source Type: news

What Is Multiple Myeloma Cancer and Is It Curable?
Colin Powell had a form of blood cancer that saps natural immunity and also undermines the effects of vaccines like the ones used against Covid-19. (Source: NYT Health)
Source: NYT Health - October 18, 2021 Category: Consumer Health News Authors: Gina Kolata Tags: Multiple Myeloma Bone Marrow Deaths (Fatalities) Immune System Blood Powell, Colin L Source Type: news

What Colin Powell ’s COVID-19 Death Says About the Current State of the Pandemic
The death of Colin Powell, an 84-year-old former four-star general who served as Chairman of the Joint Chiefs of Staff under U.S. President George H.W. Bush and Secretary of State under President George W. Bush and is perhaps best known for his role in bringing the U.S. into its second war in Iraq, is a high-profile reminder of a grim reality: COVID-19 is not just a pandemic of the unvaccinated, as current president Joe Biden likes to say, but a pandemic of the elderly, too. From early on in the pandemic, we’ve known the virus disproportionately kills older people, and the overall data make that pretty clear: About 5...
Source: TIME: Health - October 18, 2021 Category: Consumer Health News Authors: Alex Fitzpatrick Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

Colin Powell had been treated for a cancer that severely impairs the immune system, lowering coronavirus vaccine effectiveness
- The... (Source: Reuters: Health)
Source: Reuters: Health - October 18, 2021 Category: Consumer Health News Source Type: news

Powell's age and cancer bout left him vulnerable to COVID
Despite getting vaccinated against COVID-19, Colin Powell remained vulnerable to the virus because of his advanced age and history of cancer (Source: ABC News: Health)
Source: ABC News: Health - October 18, 2021 Category: Consumer Health News Tags: Health Source Type: news

Why Colin Powell's cancer likely reduced his protection from the Covid-19 vaccine
- CNN Edition * U.S., * International, * Arabic, *... (Source: Reuters: Health)
Source: Reuters: Health - October 18, 2021 Category: Consumer Health News Source Type: news

Colin Powell ’s Passing Highlights The Need For More People To Get Vaccinated
Powell's blood cancer likely reduced the protection he received from Covid-19 vaccination. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 18, 2021 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma & Source Type: news

Colin Powell ’s Passing Highlights The Need For More People To Get Vaccinated Against Covid-19
Powell's blood cancer likely reduced the protection he received from Covid-19 vaccination. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 18, 2021 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science Editors' Pick editors-pick Coronavirus business pharma & Source Type: news

FDA Panel Votes to Recommend Moderna COVID-19 Booster Shot
The COVID-19 vaccine made by Moderna is the second to get the greenlight from a panel of experts assigned to advise the Food and Drug Administration (FDA). On Thursday afternoon, a 19-member committee voted unanimously in favor of advising the FDA to recommend booster shots for people who have previously been vaccinated with Moderna’s COVID-19 vaccine. It’s now up to the FDA to make a final decision, which the Centers for Disease Control’s (CDC) Advisory Committee on Immunization Practices will then consider shortly in coming up with the final recommendation for who should get the Moderna booster. Moderna...
Source: TIME: Health - October 14, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Researchers Open Phase I Clinical Trial of Cryoablation with Keytruda
Memorial Sloan Kettering Cancer Center in New York City has opened a novel clinical trial that combines the immunotherapy drug Keytruda with cryoablation for patients with unresectable malignant mesothelioma. The phase I trial opened in September and will be available at seven Memorial Sloan Kettering locations in the New York City/New Jersey area. Cryoablation, which is also known as cryotherapy or cryosurgery, is a treatment that freezes localized tumors with argon gas or liquid nitrogen. It has been used effectively with liver, kidney and prostate cancers, but its use with mesothelioma has been limited because of ...
Source: Asbestos and Mesothelioma News - October 14, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

The Delta Variant Is Forcing New Zealand To Find a Safe Way Out of Its ‘Zero-COVID’ Strategy
For much of the pandemic, Aotearoa New Zealand’s COVID-19 response has ranked as one of the best in the world. We have been living in a parallel world, one of a small handful of countries to follow an elimination strategy. That strategy has meant that we have had very few COVID-19 cases and deaths. And when I say very few, I mean it. Until August this year, there had been just over 2,800 confirmed cases and 26 deaths. We have lived much of the pandemic with daily life almost unrestricted. As someone who follows the global situation closely it has been surreal. I’ve spent much of this pandemic worried that New Z...
Source: TIME: Health - October 14, 2021 Category: Consumer Health News Authors: Siouxsie Wiles Tags: Uncategorized COVID-19 Source Type: news

Africa: UN Honours Henrietta Lacks, Whose Cells Transformed Medical Research Worldwide
[UN News] For the past seven decades, the cells of Henrietta Lacks, a Black American woman who died of cervical cancer, have saved countless lives, and made numerous scientific breakthroughs possible, such as the human papillomavirus and polio vaccines, drugs for HIV treatment, together with cancer and COVID-19 research. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 14, 2021 Category: African Health Source Type: news

UN honours  Henrietta Lacks, whose cells transformed medical research worldwide 
For the past seven decades, the cells of Henrietta Lacks, a Black American woman who died of cervical cancer, have saved countless lives, and made numerous scientific breakthroughs possible, such as the human papillomavirus and polio vaccines, drugs for HIV treatment, together with cancer and COVID-19 research.    (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - October 13, 2021 Category: International Medicine & Public Health Source Type: news

Top 6 ways humans clog their own blood, leading to early death by heart attacks, strokes, cancer and VACCINES
(Natural News) Most of the chronic, degenerative diseases so popular in America today barely existed just four generations ago. Then came commercial cigarettes promoted by doctors, processed food promoted on television, and pharmaceutical concoctions to alleviate symptoms of blood diseases and cell disorders that are all preventable. No other nation on earth consumes as much... (Source: NaturalNews.com)
Source: NaturalNews.com - October 13, 2021 Category: Consumer Health News Source Type: news

He Was Shot by a Stranger but Treated Like a Criminal When He Reached the ER
When Greg Jackson Jr. thinks about the night he was shot, the most painful part of the memory isn’t that he almost died. It’s not the six surgeries he underwent, the half-year bedridden, or the image of his younger cousin using a shirt as a tourniquet to save his life. It’s not even the thought of the gunman. What brings on a flood of resentment is his reception at the hospital. After he was rolled off the ambulance on a stretcher, still clad in his bloody clothes, police officers—not doctors or nurses—greeted him and began peppering him with questions. Where was he when the shots rang out? W...
Source: TIME: Health - October 13, 2021 Category: Consumer Health News Authors: Melissa Chan Tags: Uncategorized COVID-19 Guns Health Care healthscienceclimate nationpod Source Type: news

Data up to 8-years for Roche ’s OCREVUS (ocrelizumab) show early and ongoing treatment significantly reduced risk of requiring a walking aid in relapsing multiple sclerosis and disability progression in primary progressive multiple sclerosis
Basel, 13 October 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new long-term data that reinforce the benefit of early initiation and ongoing treatment of OCREVUS® (ocrelizumab) on disability progression in relapsing multiple sclerosis (RMS) and primary progressive MS (PPMS), as well as safety outcomes for an analysis of shorter 2-hour infusion in minority populations. OCREVUS data from all clinical trials consistently show a favourable benefit-risk profile over eight years. Roche and research partners will also present four late-breaking abstracts to share the latest data regarding COVID-19 and vacci...
Source: Roche Media News - October 13, 2021 Category: Pharmaceuticals Source Type: news

Data up to 8-years for Roche ’s OCREVUS (ocrelizumab) show early and ongoing treatment significantly reduced risk of requiring a walking aid in relapsing multiple sclerosis and disability progression in primary progressive multiple sclerosis
Basel, 13 October 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new long-term data that reinforce the benefit of early initiation and ongoing treatment of OCREVUS® (ocrelizumab) on disability progression in relapsing multiple sclerosis (RMS) and primary progressive MS (PPMS), as well as safety outcomes for an analysis of shorter 2-hour infusion in minority populations. OCREVUS data from all clinical trials consistently show a favourable benefit-risk profile over eight years. Roche and research partners will also present four late-breaking abstracts to share the latest data regarding COVID-19 and vacci...
Source: Roche Investor Update - October 13, 2021 Category: Pharmaceuticals Source Type: news

Covid success of mRNA vaccines opens way to a new generation of drugs
Personalised cancer treatments are among those being developed using a technology once distrusted by big pharma (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - October 13, 2021 Category: Pharmaceuticals Source Type: news

Tunisia: Health Ministry to Hold Concurrently Covid-19 Vaccination Campaign and Breast Cancer Screening October 16-17
[Tunis Afrique Presse] Tunis/Tunisia -- The Health Ministry will hold concurrently a coronavirus vaccination campaign and breast cancer screening, in the interior regions of the country's north. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 12, 2021 Category: African Health Source Type: news

Despite Scares from COVID Vaccine, Mammograms Still Vital
We’ve known for months now that COVID-19 vaccines can cause a reaction that may give women a breast cancer scare. But, scientists and doctors say, mammograms remain as important as ever. (Source: WebMD Health)
Source: WebMD Health - October 11, 2021 Category: Consumer Health News Source Type: news

Confusion over booster and third Covid vaccine could be putting patients in 'harm's way'
VULNERABLE patients could be slipping through the net ahead of a nasty winter as confusion mounts over the difference between the third Covid vaccine and the booster shot, warns blood cancer charity Myeloma UK. What are the differences between the two and why is the confusion posing a grave health risk to patients? (Source: Daily Express - Health)
Source: Daily Express - Health - October 8, 2021 Category: Consumer Health News Source Type: news

Janssen Submits Application Seeking U.S. FDA Approval of STELARA ® (ustekinumab) for the Treatment of Pediatric Patients With Juvenile Psoriatic Arthritis
HORSHAM, PENNSYLVANIA, October 8, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking expanded approval of STELARA® (ustekinumab) to treat pediatric patients ages 5 years and older with juvenile psoriatic arthritis (jPsA).The filing is supported by extrapolation of data from nine studies across both adult trials in active PsA and adult and pediatric studies in moderate to severe plaque psoriasis, totaling 3,997 patients evaluated across these closely associa...
Source: Johnson and Johnson - October 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

New Analysis Presented by Janssen at United European Gastroenterology Week (UEGW) Demonstrates Long-Term Safety Profile for STELARA ® (ustekinumab) in Older Patients Across Approved Indications
SPRING HOUSE, PENNSYLVANIA, October 4, 2021 – Today, the Janssen Pharmaceutical Companies of Johnson & Johnson announced a new analysis of STELARA® (ustekinumab) pooled safety data from 13 clinical studies across approved indications, showing rates of key safety events among adults 60 years and older treated with STELARA for up to five yearsa were similar to rates observed with placebo during the control phase of these trials.1,b Approved indications included adults with moderately to severely active Crohn’s disease (CD), moderately to severely active ulcerative colitis (UC), moderate to severe plaque p...
Source: Johnson and Johnson - October 4, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Why Can ’t I Get A COVID-19 Booster Shot If I’ve Been Vaccinated With Moderna or J & J?
There’s been quite a bit of news about COVID-19 booster shots lately, and it’s been more confusing than reassuring. Public health officials don’t agree on whether everyone needs a booster yet, and in the same way that the vaccines were rolled out to different groups of people one category at a time as government agencies reviewed studies to make sure they were safe and effective, boosters are being doled out to certain people first. Here’s where we stand for now. If the vaccines work, why do I need a booster? The three vaccines that are currently available in the U.S.—from Pfizer-BioNTech, Mod...
Source: TIME: Health - September 30, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

Fighting wave of misinfo, YouTube bans false vaccine claims
Video-sharing platform YouTube has announced sweeping and immediate bans on false claims that vaccines are dangerous and cause health issues like autism, cancer or infertility (Source: ABC News: Health)
Source: ABC News: Health - September 29, 2021 Category: Consumer Health News Tags: Health Source Type: news

MSD Pharmaceuticals launches gender-neutral HPV vaccine GARDASIL 9 in India
"Launching GARDASIL 9 is a crucial step towards advancing the mission of building a healthy young India by reducing the disease burden of HPV-related cancers and disease in the country," MSD India Region Managing Director Rehan A Khan said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 29, 2021 Category: Pharmaceuticals Source Type: news

Trials Show COVID Vaccines Well Worth It for Cancer Patients
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 24, 2021 Category: Cancer & Oncology Tags: Infections, Oncology, Pharmacy, Research, News, Source Type: news

South Africa: Covid-19, Cancer Vaccines Initiative to Revolutionise South Africa's Healthcare
[SAnews.gov.za] President Cyril Ramaphosa has hailed a new COVID-19 and cancer vaccine initiative launched by world-renowned healthcare extraordinaire Dr Patrick Soon-Shiong as a game changer for South Africa's healthcare and the pharmaceutical industry. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 24, 2021 Category: African Health Source Type: news

South Africa: President Cyril Ramaphosa Attends Launch Announcement By Dr Soon-Shiong of NantAfrica Covid-19 and Cancer Vaccine Initiative, 23 Sept
[Govt of SA] President Cyril Ramaphosa will be the guest of honour today, Thursday, 23 September 2021, at an announcement by Dr Patrick Soon-Shiong, founder of the multinational conglomerate, NantWorks LLC, of an ambitious initiative to build capacity for advanced healthcare in Africa. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 24, 2021 Category: African Health Source Type: news

Trials Show COVID Vaccines Well Worth It for Cancer Patients
Title: Trials Show COVID Vaccines Well Worth It for Cancer PatientsCategory: Health NewsCreated: 9/24/2021 12:00:00 AMLast Editorial Review: 9/24/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - September 24, 2021 Category: Cancer & Oncology Source Type: news

HPV Vaccine Will Have Modest Impact on Oropharynx Cancer Incidence by 2045
However, reductions in oropharynx cancer incidence should be seen among young and middle - aged adults (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 23, 2021 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Infections, Internal Medicine, Nursing, Oncology, ENT, Pediatrics, Pharmacy, Journal, Source Type: news

South Africa: President to Attend Launch Announcement By Dr Soon-Shiong of Nantafrica Covid-19 and Cancer Vaccine Initiative
[Govt of SA] President Cyril Ramaphosa will be the guest of honour today, Thursday, 23 September 2021, at an announcement by Dr Patrick Soon-Shiong, founder of the multinational conglomerate, NantWorks LLC, of an ambitious initiative to build capacity for advanced healthcare in Africa. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 23, 2021 Category: African Health Source Type: news

Judge gives Dutch boy OK for vaccine amid parental dispute
A 12-year-old boy has gone to court in the Netherlands to get permission to receive a COVID-19 vaccine so he can visit his grandmother who is battling lung cancer (Source: ABC News: Health)
Source: ABC News: Health - September 23, 2021 Category: Consumer Health News Tags: Health Source Type: news

South Africa: NantAfrica to Launch Ambitious Covid-19, Cancer Vaccine Initiative
[SAnews.gov.za] President Cyril Ramaphosa will later today attend an announcement by Dr Patrick Soon-Shiong, founder of the multinational conglomerate, NantWorks LLC, of an ambitious initiative to build capacity for advanced health care in Africa. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 23, 2021 Category: African Health Source Type: news

Covid vaccines protect patients with cancer against virus, says new study
COVID vaccines for cancer patients are just as effective for those reported in the general population, according to the findings of a new study. (Source: Daily Express - Health)
Source: Daily Express - Health - September 22, 2021 Category: Consumer Health News Source Type: news

Uganda: Health Ministry to Introduce HPV Vaccine at 5 Years
[Independent (Kampala)] Kampala -- The Ministry of Health is planning to reduce the age at which girls get the Human Papilloma Vaccines which protects against cervical cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 20, 2021 Category: African Health Source Type: news

New Data on RYBREVANT ® (amivantamab-vmjw) in Combination with Lazertinib Show Early Activity in Patients with Non-Small Cell Lung Cancer Whose Disease Has Progressed After Both Osimertinib and Platinum-Based Chemotherapy
September 19, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced preliminary results from the Phase 1b CHRYSALIS-2 (NCT04077463) study evaluating RYBREVANT® (amivantamab-vmjw) in combination with lazertinib in the treatment of patients with non-small cell lung cancer (NSCLC) characterized by epidermal growth factor receptor (EGFR) exon 19 deletion or L858R mutations whose disease had progressed after treatment with osimertinib and platinum chemotherapy.[i] While previously reported results have demonstrated durable responses with RYBREVANT® in combination with...
Source: Johnson and Johnson - September 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

RYBREVANT ® (amivantamab-vmjw) Provides Higher Activity and Longer Duration of Response When Used in Combination with Lazertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer Who Have Failed Osimertinib
September 19, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced a new analysis from the CHRYSALIS (NCT02609776) study evaluating RYBREVANT® (amivantamab-vmjw) monotherapy and a combination regimen with lazertinib in advanced non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations who progressed after osimertinib.[1] The analysis showed higher activity and longer duration of response (DOR) in patients treated with the combination therapy, demonstrating the potential benefit of targeting the extracellular (outer) and catal...
Source: Johnson and Johnson - September 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

FDA Panel Recommends Against Following White House Plan for Booster Doses for All
A U.S. Food and Drug Administration (FDA) committee voted unanimously Friday to recommend booster doses of Pfizer-BioNTech’s COVID-19 vaccine for those over age 65 and those at higher risk of exposure to the virus, including healthcare, frontline and essential workers, under emergency use authorization, but stopped short of recommending boosters for the general population. (Boosters have already been authorized for those with compromised immune systems.) Pfizer-BioNTech had originally requested that the FDA consider full approval of a booster dose for all people who have been vaccinated with its shot. The 18 members ...
Source: TIME: Health - September 18, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

Janssen Presents Results from Phase 1b/2 NORSE Study in Patients with Metastatic or Locally Advanced Urothelial Carcinoma Treated with BALVERSA ® (erdafitinib) in Combination with Cetrelimab, a PD-1 Inhibitor
September 17, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the Phase 1b/2 NORSE (NCT03473743) study evaluating BALVERSA® (erdafitinib) in combination with cetrelimab, an anti-programmed cell death protein 1 (PD-1) monoclonal antibody, compared to BALVERSA® monotherapy in patients with locally advanced or metastatic urothelial carcinoma (mUC) with fibroblast growth factor receptor (FGFR)3 or FGFR2 genetic alterations who are ineligible for cisplatin, a current standard of care treatment for mUC. The results were highlighted in an oral present...
Source: Johnson and Johnson - September 17, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Mesothelioma Research, COVID Findings Featured at IASLC Conference
This study, performed during the pre-vaccine period of the pandemic, once again demonstrates the importance of vaccination against COVID-19,” said Dr. Susana Cedres, a medical oncologist with Vall d’Hebron Hospital. “Malignant pleural mesothelioma patients are particularly vulnerable to COVID-19.” Cedres said since the subsequent rollout of the COVID-19 vaccines, no positive cases have been attributed to pleural mesothelioma patients at the hospital. The average age of the seven patients was 62. All had the epithelioid histology of mesothelioma and two were receiving oncologic treatment at the...
Source: Asbestos and Mesothelioma News - September 15, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Idaho doctor reports "20 times increase" in cancer among those "vaccinated" for covid
(Natural News) Dr. Ryan Cole, a board-certified pathologist and diagnostics lab owner and operator based out of Idaho, has released shocking new information about how Wuhan coronavirus (Covid-19) “vaccines” are causing a massive “uptick” in autoimmune diseases and cancer. In a video produced by the Idaho state government’s “Capitol Clarity” project, Cole revealed how he... (Source: NaturalNews.com)
Source: NaturalNews.com - September 14, 2021 Category: Consumer Health News Source Type: news

Zambia: Scaling Up Cervical Cancer Awareness Among Girls Vital
[Times of Zambia] As the COVID-19 pandemic and its vaccines take centre stage, concerns of the rising number of children who are missing routine vaccinations from last year have been observed. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 13, 2021 Category: African Health Source Type: news

What Are the Advantages and Disadvantages of Different Renal Replacement Therapies?
Discussion Kidneys are amazing in that they filter the blood, eliminate toxins, balance fluids and electrolytes plus have a lot of reserve to do the job they need to do even when injured. Therefore, depending on the problem, chronic renal disease (CRD) often allows time before renal replacement therapy (RRT) is needed. RRT currently is dialysis (peritoneal or hemodialysis) or renal transplant. In general, the patient’s own kidneys do the best job for them but there is always a balance between the problems of CRD and its management, versus the potentially improved renal function with RRT. RRT itself though has a diffe...
Source: PediatricEducation.org - September 13, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

I Didn ’t Want to Push My Aunt to Get the Vaccine. Now I Live With Regrets
In normal times, the ICU is a dreadful place. Sickness lingers like a fog. You can feel it, sense it, even hear it—the machinery pumping, the alarms ringing, the nurses scrambling. In pandemic times, the ICU is chilling. Death lives here. Medical staff members wear green biohazard suits, face shields, latex gloves and shoe coverings. Strips of red tape—“ISOLATION,” they read—mark the windows and doors of individual rooms. Behind each is a patient who cannot breathe on their own, kept alive by a ventilation machine that is connected to an invasive tube running down their windpipe and into the l...
Source: TIME: Health - September 12, 2021 Category: Consumer Health News Authors: Ross Dellenger Tags: Uncategorized Source Type: news